Association of Synchronous Four-limb blOod pRessure and Pulse Wave velocIty With Cardiovascular Events

NCT ID: NCT03521739

Last Updated: 2018-05-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A multicenter prospective registry planned to recruit more than 100 000 patients 50 years old and older was carried out in China. This primary purpose of this study was to evaluate the association of synchronous four-limb blood pressure and pulse wave velocity with cardiovascular events. The secondary purpose was to evaluate the incidence rate,prevalence rate, value of diagnosis for peripheral arterial occlusive disease, and to follow up the effects of revascularization on cardiovascular events.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Although many studies with the correlation between synchronous four-limb blood pressure and pulse velocity measurement and cardiovascular outcomes have existed currently, the sample sizes are relatively small and the data on Chinese populations are lacking.Therefore, a multicenter prospective registry planned to recruit more than 100 000 patients aged 50 years old and older was carried out in China. This primary purpose of this study was to evaluate the association of synchronous four-limb blood pressure and pulse wave velocity with cardiovascular events in chinese populations. The secondary purpose was to evaluate the incidence rate,prevalence rate, value of diagnosis for peripheral arterial occlusive disease, and to follow up the effects of revascularization on cardiovascular events.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Pressure Pulse Wave Analysis Ankle Brachial Index Patient Outcome Assessment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age ≥ 50 years old at the time of informed consent
2. Chinese populations in hospital, community and physical examination center

Exclusion Criteria

1. Patients with lack of limb,malformation of limbs, severe limb trauma or infection.
2. Serious organic disease affecting the quality of life, such as tumors, massive cerebral infarction, uremia, and etc.
Minimum Eligible Age

50 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Xiongjing Jiang

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xiongjing Jiang, MD

Role: PRINCIPAL_INVESTIGATOR

Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beijing Renhe Hospital

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

Chinese PLA General Hospital

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College

Beijing, Beijing Municipality, China

Site Status RECRUITING

Daping Hospital

Chongqing, Chongqing Municipality, China

Site Status NOT_YET_RECRUITING

The Second Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China

Site Status NOT_YET_RECRUITING

Lanzhou University Second Hospital

Lanzhou, Gansu, China

Site Status NOT_YET_RECRUITING

Guangdong General Hospital

Guangzhou, Guangdong, China

Site Status NOT_YET_RECRUITING

The Eighth Affiliated Hospital of Sun Yat-sen University

Shenzhen, Guangdong, China

Site Status NOT_YET_RECRUITING

Kailuan General Hospital

Tangshan, Hebei, China

Site Status NOT_YET_RECRUITING

The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China

Site Status NOT_YET_RECRUITING

The Second Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China

Site Status NOT_YET_RECRUITING

The General Hospital of Shenyang Military

Shenyang, Liaoning, China

Site Status NOT_YET_RECRUITING

Ruijin Hospital, Shanghai Jiaotong University School of Medicine

Shanghai, Shanghai Municipality, China

Site Status NOT_YET_RECRUITING

Shanghai East Hospital

Shanghai, Shanghai Municipality, China

Site Status NOT_YET_RECRUITING

Shanxi Cardiovascular Hospital

Taiyuan, Shanxi, China

Site Status NOT_YET_RECRUITING

The First Affiliated Hospital of Xi'an Jiaotong University

Xi’an, Shanxi, China

Site Status NOT_YET_RECRUITING

Xi'an NO.3 Hospital

Xi’an, Shanxi, China

Site Status NOT_YET_RECRUITING

West China Hospital of Sichuan University

Chengdu, Sichuan, China

Site Status NOT_YET_RECRUITING

Zhejiang Hospital

Hangzhou, Zhejiang, China

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Xiongjing Jiang, MD

Role: CONTACT

86-1088322385

Hui Dong, MD

Role: CONTACT

+8615810161393

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yan Li, MD

Role: primary

86-010-69242469

Yu Wang, MD

Role: primary

Xiongjing Jiang, MD

Role: primary

86-1088322385

Zhigang Zhao, MD

Role: primary

86-023-68811229

Jin Huang, MD

Role: primary

Jing Yu, MD

Role: primary

86-0931-8942262

Jianfang Luo, MD

Role: primary

86-020-83827812

Nan Jia, MD

Role: primary

86-0755-83982222

Shouling Wu, MD

Role: primary

Zeqi Zheng, MD

Role: primary

86-0791-88692748

Ping Li, MD

Role: primary

86-0791-86297662

Xiaozeng Wang, MD

Role: primary

86-024-28886666

Jianzhong Xu, MD

Role: primary

86-021-64370045

Qi Zhang, MD

Role: primary

Bin Yang, MD

Role: primary

86-0351-5661145

Hongyan Tian, MD

Role: primary

86-029-85252580

Kang Cheng, MD

Role: primary

86-029-61895566

Xiaoping Chen, MD

Role: primary

86-028-85422114

Lijiang Tang, MD

Role: primary

86-0571-87987373

References

Explore related publications, articles, or registry entries linked to this study.

An X, Dong H, Deng Y, Chen Y, Zou Y, Zhang W, Jiang X. Evaluation of the role of combining inter-arm systolic pressure difference and derivatives of pulse volume recording in detecting subclavian artery stenosis. Front Cardiovasc Med. 2022 Sep 15;9:962610. doi: 10.3389/fcvm.2022.962610. eCollection 2022.

Reference Type DERIVED
PMID: 36186962 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018-993

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.